Pediatric hydrocephalus outcomes in Lusaka, Zambia.
Cautery
Central Nervous System Infections
/ complications
Child
Child, Preschool
Choroid Plexus
Cohort Studies
Endoscopy
Female
Follow-Up Studies
Humans
Hydrocephalus
/ epidemiology
Male
Postoperative Complications
/ epidemiology
Retrospective Studies
Third Ventricle
/ surgery
Treatment Outcome
Ventriculoperitoneal Shunt
Ventriculostomy
Zambia
/ epidemiology
Zambia
hydrocephalus
shunt
spina bifida
sub-Saharan Africa
surgical outcomes
Journal
Journal of neurosurgery. Pediatrics
ISSN: 1933-0715
Titre abrégé: J Neurosurg Pediatr
Pays: United States
ID NLM: 101463759
Informations de publication
Date de publication:
11 Sep 2020
11 Sep 2020
Historique:
received:
17
03
2020
accepted:
21
05
2020
pubmed:
12
9
2020
medline:
26
2
2022
entrez:
11
9
2020
Statut:
epublish
Résumé
Hydrocephalus is a global disease that disproportionally impacts low- and middle-income countries. Limited data are available from sub-Saharan Africa. This study aims to be the first to describe pediatric hydrocephalus epidemiology and outcomes in Lusaka, Zambia. This retrospective cohort study included patients < 18 years of age who underwent surgical treatment for hydrocephalus at Beit-CURE Hospital and the University Teaching Hospital in Lusaka, Zambia, from August 2017 to May 2019. Surgeries included ventriculoperitoneal shunt insertions, revisions, and endoscopic third ventriculostomies (ETVs) with or without choroid plexus cauterization (CPC). A descriptive analysis of patient demographics, clinical presentation, and etiologies was summarized, followed by a multivariable analysis of mortality and 90-day complications. A total of 378 patients met the inclusion criteria. The median age at first surgery was 5.5 (IQR 3.1, 12.7) months, and 51% of patients were female (n = 193). The most common presenting symptom was irritability (65%, n = 247), followed by oculomotor abnormalities (54%, n = 204). Postinfectious hydrocephalus was the predominant etiology (65%, n = 226/347), and 9% had a myelomeningocele (n = 32/347). It was the first hydrocephalus surgery for 87% (n = 309) and, of that group, 15% underwent ETV/CPC (n = 45). Severe hydrocephalus was common, with 42% of head circumferences more than 6 cm above the 97th percentile (n = 111). The median follow-up duration was 33 (IQR 4, 117) days. The complication rate was 20% (n = 76), with infection being most common (n = 29). Overall, 7% of the patients died (n = 26). Postoperative complication was significantly associated with mortality (χ2 = 81.2, p < 0.001) with infections and CSF leaks showing the strongest association (χ2 = 14.6 and 15.2, respectively, p < 0.001). On adjusted multivariable analysis, shunt revisions were more likely to have a complication than ETV/CPC or primary shunt insertions (OR 2.45 [95% CI 1.26-4.76], p = 0.008), and the presence of any postoperative complication was the only significant predictor of mortality (OR 42.9 [95% CI 12.3-149.1], p < 0.001). Pediatric postinfectious hydrocephalus is the most common etiology of hydrocephalus in Lusaka, Zambia, which is similar to other countries in sub-Saharan Africa. Most children present late with neglected hydrocephalus. Shunt revision procedures are more prone to complication than ETV/CPC or primary shunt insertion, and postoperative complications represent a significant predictor of mortality in this population.
Identifiants
pubmed: 32916646
doi: 10.3171/2020.5.PEDS20193
pmc: PMC7947024
mid: NIHMS1670203
doi:
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
624-635Subventions
Organisme : FIC NIH HHS
ID : D43 TW009337
Pays : United States
Organisme : FIC NIH HHS
ID : D43 TW010543
Pays : United States
Références
Childs Nerv Syst. 2019 Apr;35(4):637-644
pubmed: 30552445
PLoS One. 2018 Oct 1;13(10):e0204926
pubmed: 30273390
J Neurosurg Pediatr. 2016 Dec;25(6):655-662
pubmed: 27564786
World J Surg. 2018 Nov;42(11):3508-3513
pubmed: 29785694
J Neurosurg. 2004 Feb;100(2 Suppl Pediatrics):90-7
pubmed: 14758935
Neurology. 2015 May 12;84(19):1988-90
pubmed: 25964478
Pediatr Neurosurg. 2017;52(6):401-408
pubmed: 28002814
J Biomed Inform. 2009 Apr;42(2):377-81
pubmed: 18929686
J Urol. 2017 Sep;198(3):511-519
pubmed: 28286066
Lancet. 1999 Dec 4;354(9194):1955-61
pubmed: 10622298
J Neurosurg Pediatr. 2015 Jun;15(6):573-9
pubmed: 26030328
Scand J Public Health. 2016 Feb;44(1):2-5
pubmed: 26392424
J Neurosurg Pediatr. 2019 May 10;24(2):120-127
pubmed: 31075763
J Neurosurg Pediatr. 2011 Jul;8(1):22-9
pubmed: 21721884
J Neurosurg Pediatr. 2014 Feb;13(2):140-4
pubmed: 24313655
Neurosurgery. 2001 Jun;48(6):1344-7
pubmed: 11383739
Neurosurgery. 2007 Sep;61(3):557-62; discussion 562-3
pubmed: 17881969
J Neurosurg Pediatr. 2014 Nov;14(5):439-46
pubmed: 25171723
World Neurosurg. 2018 May;113:425-435
pubmed: 29702966
World Neurosurg. 2010 Apr;73(4):296-300
pubmed: 20849782
Int J Environ Res Public Health. 2018 Aug 22;15(9):
pubmed: 30131480
N Engl J Med. 2017 Dec 21;377(25):2456-2464
pubmed: 29262276
Asian J Neurosurg. 2014 Oct-Dec;9(4):233-4
pubmed: 25685221
World J Surg. 2014 Jul;38(7):1605-9
pubmed: 24722867
J Neurosurg. 2005 Jan;102(1 Suppl):1-15
pubmed: 16206728
World Neurosurg. 2017 Feb;98:397-402
pubmed: 27506407
Lancet Infect Dis. 2010 May;10(5):317-28
pubmed: 20417414
J Neurosurg Pediatr. 2010 Oct;6(4):329-35
pubmed: 20887104
Afr J Disabil. 2016 Dec 02;5(1):267
pubmed: 28730060
J Neurosurg Pediatr. 2017 Nov;20(5):423-431
pubmed: 28885096
Lancet. 2019 Oct 26;394(10208):1530-1539
pubmed: 31522843
J Neurosurg. 2018 Apr 27;130(4):1065-1079
pubmed: 29701543
BMC Res Notes. 2017 Dec 8;10(1):724
pubmed: 29221493
BMC Pregnancy Childbirth. 2020 Jan 6;20(1):20
pubmed: 31906880
Int J Gynaecol Obstet. 2016 Jan;132(1):64-7
pubmed: 26439856
PLoS One. 2017 Sep 14;12(9):e0184432
pubmed: 28910302
J Neurosurg Pediatr. 2008 Nov;2(5):310-6
pubmed: 18976099
J Pediatr. 2009 Aug;155(2):254-9.e1
pubmed: 19446842